Sonoma Pharmaceuticals (SNOA) reports Q2 result

Sonoma Pharmaceuticals (NASDAQ: SNOA) reported Q2 EPS of ($0.32). Revenue for the quarter came in at $5.6 million.

For earnings history and earnings-related data on Sonoma Pharmaceuticals (SNOA) click here.

You May Also Be Interested In

• Is the global equity rally broadening? UBS weighs in
• Piper Sandler on Chewy Inc. (CHWY): 'Increasing Focus on Share Gains'
• Rithm Capital Corp. (RITM) PT Lowered to $14 at UBS on Higher for Longer Rates